DiscoBio News

AstraZeneca and Medicines for Malaria Venture (MMV) announced a collaborative agreement designed to identify novel candidate drugs for the treatment of malaria. Discovery Biology will undertake the screenign of 500,000 compounds on behalf of MMV. Read more here: AZ & MMV article